ERIE Q4 operating income before taxes falls 5.7% to USD 157.71 million

Reuters
02/24
ERIE Q4 operating income before taxes falls 5.7% to USD 157.71 million

Erie Indemnity reported FY 2025 net income of USD 559.34 million, with net income per diluted share of USD 10.69, and operating income of USD 717.18 million. Total operating revenue was USD 4.07 billion in FY 2025, including management fee revenue for policy issuance and renewal services of USD 3.13 billion and administrative services reimbursement revenue of USD 836.64 million. Net investment income was USD 85.84 million in FY 2025, while the company recorded a USD 100 million contribution to a charitable foundation, reflecting a USD 100 million charitable contribution to the Erie Insurance Foundation formed in 2025 to support long-term charitable contributions and grantmaking. For Q4 2025, net income was USD 63.38 million, or USD 1.21 per diluted share, and operating income was USD 157.71 million. Total operating revenue in Q4 was USD 951.02 million, including management fee revenue for policy issuance and renewal services of USD 727.63 million, while net investment income was USD 24.83 million. Erie Indemnity said the after-tax impact of the USD 100 million charitable contribution reduced net income by USD 80.6 million, or USD 1.54 per diluted share, for both Q4 and FY 2025.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Erie Indemnity Company published the original content used to generate this news brief via PR Newswire (Ref. ID: 202602231615PR_NEWS_USPR_____NE91677) on February 23, 2026, and is solely responsible for the information contained therein.

應版權方要求,你需要登入查看該內容

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10